Literature DB >> 28701479

On the origin of relapse in AML.

Brian A Jonas1.   

Abstract

Preexisting therapy-resistant leukemia stem cell populations underlie the cellular origin of relapse in acute myeloid leukemia.
Copyright © 2017, American Association for the Advancement of Science.

Entities:  

Mesh：

Year:  2017        PMID： 28701479      PMCID： PMC5573257          DOI： 10.1126/scitranslmed.aan8205

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN： 1946-6234            Impact factor:   17.956


  1 in total

1.  Tracing the origins of relapse in acute myeloid leukaemia to stem cells.

Authors:  Liran I Shlush; Amanda Mitchell; Lawrence Heisler; Sagi Abelson; Stanley W K Ng; Aaron Trotman-Grant; Jessie J F Medeiros; Abilasha Rao-Bhatia; Ivana Jaciw-Zurakowsky; Rene Marke; Jessica L McLeod; Monica Doedens; Gary Bader; Veronique Voisin; ChangJiang Xu; John D McPherson; Thomas J Hudson; Jean C Y Wang; Mark D Minden; John E Dick
Journal:  Nature       Date:  2017-06-28       Impact factor: 49.962
  1 in total
  1 in total

1.  CD123 Is Consistently Expressed on NPM1-Mutated AML Cells.

Authors:  Vincenzo Maria Perriello; Ilaria Gionfriddo; Roberta Rossi; Francesca Milano; Federica Mezzasoma; Andrea Marra; Orietta Spinelli; Alessandro Rambaldi; Ombretta Annibali; Giuseppe Avvisati; Francesco Di Raimondo; Stefano Ascani; Brunangelo Falini; Maria Paola Martelli; Lorenzo Brunetti
Journal:  Cancers (Basel)       Date:  2021-01-28       Impact factor: 6.639
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.